Saturday 10 October 2026 Export all INNV data to Excel Powerpack

InnovAge Holding Corp.

INNV Healthcare Medical Care Facilities

InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025. In the quarter to June 2026, revenue grew 18.3%, EPS grew 700.0%, free cash flow grew 85.4% and total debt fell 16.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.10 0.01 −0.11%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
17.2×
Dividend yield
—
F-score
6/9
Altman Z
4.58
Beneish M
−3.10
Dividend safety
n/a

InnovAge Holding Corp. (INNV) EV/Sales

Alert me on EV/Sales

As of 9 October 2026, InnovAge Holding Corp. (INNV) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 0.4× (April 2025) to 5.4× (March 2021); the current reading is higher than 69% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 1.5× 185.02%
FY2025 0.5× (37.53%)
FY2024 0.9× (35.72%)
FY2023 1.3× 91.48%
FY2022 0.7× (82.16%)
FY2021 3.9× (21.42%)
FY2020 5.0× 0.00%
FY2019 5.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.5× 44.16%
Mar 2026 1.1× 52.14%
Dec 2025 0.7× (5.34%)
Sep 2025 0.7× 37.28%
23 more quarters

Against its own ten years

Low 0.4× High 5.4×
Ten-year median 1.0×
Current reading's percentile 69

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on INNV